Charles J. Dockendorff - 24 Jul 2025 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
Director
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Dockendorff
Issuer symbol
HAE
Transactions as of
24 Jul 2025
Net transactions value
$0
Form type
4
Filing time
25 Jul 2025, 16:25:51 UTC
Previous filing
25 Mar 2025
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dockendorff Charles J Director 125 SUMMER STREET, BOSTON /s/ Thomas V. Powers, attorney-in-fact for Mr. Dockendorff 25 Jul 2025 0001400563

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Award +2,693 +61% 7,126 24 Jul 2025 Direct F1, F2
holding HAE Common Stock 17,915 24 Jul 2025 Spouse?s Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.